- Home
- CCD vs DNA Comparison
CCD vs DNA Comparison
Compare CCD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCD
- DNA
- Stock Information
- Founded
- CCD 2014
- DNA 2008
- Country
- CCD United States
- DNA United States
- Employees
- CCD N/A
- DNA N/A
- Industry
- CCD Trusts Except Educational Religious and Charitable
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCD Finance
- DNA Health Care
- Exchange
- CCD Nasdaq
- DNA Nasdaq
- Market Cap
- CCD 661.3M
- DNA 542.6M
- IPO Year
- CCD N/A
- DNA N/A
- Fundamental
- Price
- CCD $24.65
- DNA $10.10
- Analyst Decision
- CCD
- DNA Hold
- Analyst Count
- CCD 0
- DNA 6
- Target Price
- CCD N/A
- DNA $37.80
- AVG Volume (30 Days)
- CCD 96.1K
- DNA 1.5M
- Earning Date
- CCD 01-01-0001
- DNA 11-12-2024
- Dividend Yield
- CCD 10.61%
- DNA N/A
- EPS Growth
- CCD N/A
- DNA N/A
- EPS
- CCD N/A
- DNA N/A
- Revenue
- CCD N/A
- DNA $217,951,000.00
- Revenue This Year
- CCD N/A
- DNA N/A
- Revenue Next Year
- CCD N/A
- DNA N/A
- P/E Ratio
- CCD N/A
- DNA N/A
- Revenue Growth
- CCD N/A
- DNA N/A
- 52 Week Low
- CCD $16.93
- DNA $5.26
- 52 Week High
- CCD $24.68
- DNA $74.00
- Technical
- Relative Strength Index (RSI)
- CCD 64.05
- DNA 56.46
- Support Level
- CCD $23.90
- DNA $10.48
- Resistance Level
- CCD $24.21
- DNA $9.92
- Average True Range (ATR)
- CCD 0.33
- DNA 1.14
- MACD
- CCD 0.10
- DNA -0.12
- Stochastic Oscillator
- CCD 66.67
- DNA 47.49
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operate as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.